Insider Transactions in Q3 2021 at Catalent, Inc. (CTLT)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 01
2021
|
John R Chiminski Executive Chair |
SELL
Bona fide gift
|
Direct |
11,000
-4.79%
|
-
|
|
Aug 27
2021
|
Christa Kreuzburg Director |
SELL
Payment of exercise price or tax liability
|
Direct |
199
-2.27%
|
$25,671
$129.85 P/Share
|
|
Aug 27
2021
|
Jonathan Arnold SVP, CCO & Div. Head BioP Del. |
SELL
Open market or private sale
|
Direct |
452
-0.48%
|
$58,760
$130.74 P/Share
|
|
Aug 27
2021
|
John R Chiminski Executive Chair |
SELL
Open market or private sale
|
Direct |
44,488
-8.21%
|
$5,783,440
$130.76 P/Share
|
|
Aug 27
2021
|
Steven L Fasman EVP & Chief Admin Officer |
SELL
Open market or private sale
|
Direct |
6,111
-3.81%
|
$794,430
$130.74 P/Share
|
|
Aug 27
2021
|
Aristippos Gennadios Group Pres. Pharma & Consumer |
SELL
Open market or private sale
|
Direct |
2,262
-1.9%
|
$294,060
$130.74 P/Share
|
|
Aug 27
2021
|
Michael J Grippo SVP, Strategy & Corp. Dev. |
SELL
Open market or private sale
|
Direct |
1,698
-5.26%
|
$220,740
$130.74 P/Share
|
|
Aug 27
2021
|
Scott Gunther SVP, Quality & Reg. Affairs |
SELL
Open market or private sale
|
Direct |
4,173
-6.6%
|
$542,490
$130.61 P/Share
|
|
Aug 27
2021
|
Alessandro Maselli President & CEO |
SELL
Open market or private sale
|
Direct |
3,743
-6.37%
|
$486,590
$130.74 P/Share
|
|
Aug 27
2021
|
Ricardo Pravda Chief Transformation Officer |
SELL
Open market or private sale
|
Direct |
692
-2.57%
|
$89,960
$130.74 P/Share
|
|
Aug 27
2021
|
Ricky Hopson Pres. BioProduct Delivery, CoS |
SELL
Open market or private sale
|
Direct |
1,471
-3.54%
|
$191,230
$130.74 P/Share
|
|
Aug 27
2021
|
Kay A Schmidt SVP, Enterprise Functions |
SELL
Open market or private sale
|
Direct |
825
-2.46%
|
$107,250
$130.74 P/Share
|
|
Aug 27
2021
|
Thomas P Castellano SVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,093
-5.33%
|
$272,090
$130.74 P/Share
|
|
Aug 26
2021
|
Jonathan Arnold SVP, CCO & Div. Head BioP Del. |
BUY
Grant, award, or other acquisition
|
Direct |
7,830
+14.23%
|
-
|
|
Aug 26
2021
|
John R Chiminski Executive Chair |
BUY
Grant, award, or other acquisition
|
Direct |
105,418
+27.76%
|
-
|
|
Aug 26
2021
|
Steven L Fasman EVP & Chief Admin Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,566
+12.54%
|
-
|
|
Aug 26
2021
|
Aristippos Gennadios Group Pres. Pharma & Consumer |
BUY
Grant, award, or other acquisition
|
Direct |
8,008
+11.82%
|
-
|
|
Aug 26
2021
|
Michael J Grippo SVP, Strategy & Corp. Dev. |
BUY
Grant, award, or other acquisition
|
Direct |
4,984
+23.47%
|
-
|
|
Aug 26
2021
|
Scott Gunther SVP, Quality & Reg. Affairs |
BUY
Grant, award, or other acquisition
|
Direct |
6,052
+21.4%
|
-
|
|
Aug 26
2021
|
Alessandro Maselli President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
8,008
+21.27%
|
-
|
|
Aug 26
2021
|
Ricardo Pravda Chief Transformation Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,030
+13.05%
|
-
|
|
Aug 26
2021
|
Ricky Hopson Pres. BioProduct Delivery, CoS |
BUY
Grant, award, or other acquisition
|
Direct |
4,317
+17.14%
|
-
|
|
Aug 26
2021
|
Kay A Schmidt SVP, Enterprise Functions |
BUY
Grant, award, or other acquisition
|
Direct |
2,590
+13.36%
|
-
|
|
Aug 26
2021
|
Thomas P Castellano SVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,273
+17.75%
|
-
|
|
Jul 26
2021
|
Jonathan Arnold SVP, CCO & Div. Head BioP Del. |
BUY
Grant, award, or other acquisition
|
Direct |
885
+2.2%
|
-
|
|
Jul 26
2021
|
Jonathan Arnold SVP, CCO & Div. Head BioP Del. |
SELL
Open market or private sale
|
Direct |
120
-0.31%
|
$13,560
$113.05 P/Share
|
|
Jul 26
2021
|
John R Chiminski Executive Chair |
BUY
Grant, award, or other acquisition
|
Direct |
16,461
+8.88%
|
-
|
|
Jul 26
2021
|
John R Chiminski Executive Chair |
SELL
Open market or private sale
|
Direct |
11,137
-6.81%
|
$1,258,481
$113.05 P/Share
|
|
Jul 26
2021
|
Steven L Fasman EVP & Chief Admin Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,770
+2.5%
|
-
|
|
Jul 26
2021
|
Steven L Fasman EVP & Chief Admin Officer |
SELL
Open market or private sale
|
Direct |
1,549
-2.25%
|
$175,037
$113.05 P/Share
|
|
Jul 26
2021
|
Karen Flynn Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,151
+3.12%
|
-
|
|
Jul 26
2021
|
Aristippos Gennadios Group Pres. Pharma & Consumer |
BUY
Grant, award, or other acquisition
|
Direct |
885
+1.68%
|
-
|
|
Jul 26
2021
|
Aristippos Gennadios Group Pres. Pharma & Consumer |
SELL
Open market or private sale
|
Direct |
465
-0.91%
|
$52,545
$113.05 P/Share
|
|
Jul 26
2021
|
Michael J Grippo SVP, Strategy & Corp. Dev. |
BUY
Grant, award, or other acquisition
|
Direct |
974
+5.25%
|
-
|
|
Jul 26
2021
|
Michael J Grippo SVP, Strategy & Corp. Dev. |
SELL
Open market or private sale
|
Direct |
451
-2.64%
|
$50,963
$113.05 P/Share
|
|
Jul 26
2021
|
Scott Gunther SVP, Quality & Reg. Affairs |
BUY
Grant, award, or other acquisition
|
Direct |
753
+4.45%
|
-
|
|
Jul 26
2021
|
Scott Gunther SVP, Quality & Reg. Affairs |
SELL
Open market or private sale
|
Direct |
1,079
-3.32%
|
$121,927
$113.04 P/Share
|
|
Jul 26
2021
|
Alessandro Maselli President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
3,009
+12.21%
|
-
|
|
Jul 26
2021
|
Alessandro Maselli President & CEO |
SELL
Open market or private sale
|
Direct |
993
-5.06%
|
$112,209
$113.05 P/Share
|
|
Jul 26
2021
|
Ricardo Pravda Chief Transformation Officer |
BUY
Grant, award, or other acquisition
|
Direct |
885
+7.15%
|
-
|
|
Jul 26
2021
|
Ricardo Pravda Chief Transformation Officer |
SELL
Open market or private sale
|
Direct |
458
-4.14%
|
$51,754
$113.05 P/Share
|
|
Jul 26
2021
|
Ricky Hopson Pres. BioProduct Delivery, CoS |
BUY
Grant, award, or other acquisition
|
Direct |
496
+2.91%
|
-
|
|
Jul 26
2021
|
Ricky Hopson Pres. BioProduct Delivery, CoS |
SELL
Open market or private sale
|
Direct |
360
-2.19%
|
$40,680
$113.05 P/Share
|
|
Jul 26
2021
|
Kay A Schmidt SVP, Enterprise Functions |
BUY
Grant, award, or other acquisition
|
Direct |
885
+5.87%
|
-
|
|
Jul 26
2021
|
Kay A Schmidt SVP, Enterprise Functions |
SELL
Open market or private sale
|
Direct |
547
-3.94%
|
$61,811
$113.05 P/Share
|
|
Jul 26
2021
|
Thomas P Castellano SVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,062
+6.4%
|
-
|
|
Jul 26
2021
|
Thomas P Castellano SVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
555
-3.7%
|
$62,715
$113.05 P/Share
|
|
Jul 26
2021
|
Ricci S Whitlow President, CSS |
BUY
Grant, award, or other acquisition
|
Direct |
531
+14.6%
|
-
|
|
Jul 15
2021
|
Steven L Fasman EVP & Chief Admin Officer |
SELL
Open market or private sale
|
Direct |
4,500
-3.1%
|
$495,000
$110.05 P/Share
|